The in vivo balance between B cell clonal expansion and elimination is regulated by CD95 both on B cells and in their micro-environment

Immunology and Cell Biology

Volumn 76, Issue 5, 1998, Pages 387-394

  Rathmell, Jeffrey C ^a   Goodnow, Christopher C ^a,b  

^a STANFORD UNIVERSITY   (United States)

^b Biology and Environment   (Australia)

Author keywords

B cell; CD95; CD95 ligand; Lpr

Indexed keywords

B LYMPHOCYTE ANTIGEN; CD4 ANTIGEN; FAS ANTIGEN; GLYCOPROTEIN GP 39; LYMPHOCYTE ANTIGEN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN BINDING; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; HUMORAL IMMUNITY; IMMUNOLOGICAL TOLERANCE; MOUSE; NONHUMAN; REGULATORY MECHANISM; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; B-LYMPHOCYTES; BLOTTING, NORTHERN; FLOW CYTOMETRY; IMMUNITY, CELLULAR; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; POLYMERASE CHAIN REACTION; RECEPTORS, ANTIGEN, B-CELL; RNA, MESSENGER; SPLEEN; T-LYMPHOCYTES;

ANIMALIA;

EID: 0031759825     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1711.1998.00774.x     Document Type: Article

References (41)

1. Rothstein T, Wang J, Panka D et al. Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells. Nature 1995; 374: 163-5.
2. Rathmell JC, Townsend SE, Xu JC, Flavell RA, Goodnow CC. Expansion or elimination of B cells in vivo: Dual roles for CD40-and Fas (CD95)-ligands modulated by the B cell antigen receptor. Cell 1996; 87: 319-29.
3. Lagresle C, Mondiere P, Bella C, Krammer PH, Defrance T. Concurrent engagement of CD40 and the antigen receptor protects naive and memory human B cells from APO-1/Fas-mediated apoptosis. J. Exp. Med. 1996; 183: 1377-88.
4. Wang J, Taniuchi I, Maekawa Y, Howard M, Cooper MD, Watanabe T. Expression and function of Fas antigen on activated murine B cells. Eur. J. Immunol. 1996; 26: 92-6.
5. + T cells. Nature 1995; 376: 181-4.
6. Cohen PL, Eisenberg RA. The lpr and gld genes in systemic autoimmunity: Life and death in the Fas lane. Immunol. Today 1992; 13: 427-8.
7. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992; 356: 314-17.
8. Katagiri T, Cohen PL, Eisenberg RA. The lpr gene causes an intrinsic T cell abnormality that is required for hyperproliferation. J. Exp. Med. 1988; 167: 741-51.
9. Russell JH, Rush B, Weaver C, Wang R. Mature T cells of autoimmune lpr/lpr mice have a defect in antigen-stimulated suicide. Proc. Natl Acad. Sci. USA 1993; 90: 4409-13.
10. Brunner T, Mogil R, LaFace D et al. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 1995; 373: 441-4.
11. Dhein J, Walczak H, Bäumler C, Debatin K, Krammer P. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 1995; 373: 438-41.
12. Ju S, Panka D, Cui H et al. Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 1995; 373: 444-8.
13. Nagata S, Golstein P. The Fas death factor. Science 1995; 267: 1449-56.
14. Jevnikar AM, Grusby MJ, Glimcher LH. Prevention of nephritis in major histocompatibility complex Class II-deficient MRL-lpr mice. J. Exp. Med. 1994; 179: 1137-46.
15. Sobel ES, Cohen PL, Eisenberg RA. lpr T cells are necessary for autoantibody production in lpr mice. J. Immunol. 1993; 150: 4160-7.
16. Sobel ES, Kakkanaiah VN, Kakkanaiah M, Cheek RL, Cohen PL, Eisenberg RA. T-B collaboration for autoantibody production in lpr mice is cognate and MHC-restricted. J. Immunol. 1994; 152: 6011-16.
17. Theofilopoulos AN, Balderas RS, Gozes Y et al. Association of lpr gene with graft-vs.-host disease-like syndrome. J. Exp. Med. 1985; 162: 1-18.
18. Allen RD, Marshall JD, Roths JB, Sidman CL. Bone marrow transplantation from mutant lpr/lpr mice. Functional abnormalities rather than alloantigenic differences appear to determine the development of a graft-vs.-host-like syndrome. Eur. J. Immunol. 1990; 20: 2057-66.
19. Goodnow CC, Crosbie J, Adelstein S et al. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 1988; 334: 676-82.
20. Mason DY, Jones M, Goodnow CC. Development and follicular localization of tolerant B lymphocytes in lysozyme antilysozyme IgM/IgD transgenic mice. Int. Immunol. 1992; 4: 163-75.
21. Rathmell JC, Goodnow CC. Effects of the lpr mutation on elimination and inactivation of self-reactive B cells. J. Immunol. 1994; 153: 2831-42.
22. Singer GG, Abbas AK. The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1994; 1: 365-71.
23. Hartley SB, Cooke MP, Fulcher DA et al. Elimination of self-reactive B lymphocytes proceeds in two stages: Arrested development and cell death. Cell 1993; 72: 325-35.
24. Reiner SL, Zheng S, Corry DB, Locksley RM. Constructing polycompetitor cDNAs for quantitative PCR. J Immunol. Meth. 1993; 165: 37-46.
25. Rathmell WK, Kaufmann WK, Hurt JC, Byrd LL, Chu G. DNA-dependent protein kinase is not required for accumulation of p53 or cell cycle arrest after DNA damage. Cancer Res. 1997; 57: 68-74.
26. Shokat KM, Goodnow CC. Antigen-induced B cell death and elimination during germinal-centre immune responses. Nature 1995; 375: 334-8.
27. Razvi ES, Jiang Z, Woda BA, Welsh RM. Lymphocyte apoptosis during the silencing of the immune response to acute viral infections in normal, lpr, and Bcl-2-transgenic mice. Am. J. Pathol. 1995; 147: 79-91.
28. Smith KGC, Nossal GJV, Tarlinton DM. FAS is highly expressed in the germinal center but is not required for regulation of the B-cell response to antigen. Proc. Natl Acad. Sci. USA 1995; 92: 11 628-32.
29. Roths JB, Murphy ED, Eicher EM. A new mutation, gld, that produces lymphoproliferation and autoimmunity in C3H HeJ mice. J. Exp. Med. 1984; 159: 1-20.
30. Lynch DH, Watson ML, Alderson MR et al. The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster. Immunity 1994; 1: 131-6.
31. Ramsdell F, Seaman MS, Miller RE, Tough TW, Alderson MR, Lynch DH. gld/gld mice are unable to express a functional ligand for Fas. Eur. J. Immunol. 1994; 24: 928-33.
32. Takahashi T, Tanaka M, Branna CI et al. Generalized lymphoproliferative disease in mice caused by a point mutation in the Fas ligand. Cell 1994; 76: 969-76.
33. Hahne M, Peitsch MC, Irmler M et al. Characterization of the non-functional Fas ligand of gld mice. Int. Immunol. 1995; 7: 1381-6.
34. Chu JL, Ramos P, Rosendorff A et al. Massive upregulation of the Fas ligand in lpr and gld mice: Implications for Fas regulation and the graft-versus-host disease-like wasting syndrome. J. Exp. Med. 1995; 181: 393-8.
35. Benihoud K, Bonardelle D, Bobé P, Kiger N. MRL/lpr CD4-CD8-and CD8+ Tcells, respectively, mediate Fas-dependent and perform cytotoxic pathways. Eur. J. Immunol. 1997; 27: 415-20.
36. Yasutomo K, Nagasawa H, Hisaeda H, Good RA, Kuroda Y, Himeno K. Fas system-mediated apoptosis suppresses lymphopoiesis. J. Immunol. 1996; 157: 1981-6.
37. Suda T, Takahashi T, Golstein P, Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993; 75: 1169-78.
38. Süss G, Shortman K. A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis. J. Exp. Med. 1996; 183: 1789-96.
39. Foote LC, Schneider TJ, Fischer GM et al. Intracellular signaling for inducible antigen receptor-mediated Fas resistance in B cells. J. Immunol. 1996; 157: 1878-85.
40. Weston KM, Ju S, Lu CY, Sy M. Autoreactive T cells in MRL/ MP-lpr/lpr mice: Characterization of the lymphokines produced and analysis of antigen presenting cells required. J. Immunol. 1988; 141: 1941-8.
41. Foote LC, Marshak-Rothstein A, Rothstein TL. Tolerant B lymphocytes acquire resistance to Fas-mediated apoptosis after treatment with interleukin 4 but not after treatment with specific antigen unless a surface immunoglobulin threshold is exceeded. J. Exp. Med. 1998; 187: 847-53.